Brief: Entera Bio Initiates New Research Program For Oral Glp-2
08/02/2021 13:51
Feb 8 (Reuters) - Entera Bio Ltd ENTX.O :
* ENTERA BIO INITIATES NEW RESEARCH PROGRAM FOR ORAL GLP-2
Source text for Eikon: ID:nGNX9lthG5
Further company coverage: ENTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement